SCHEMBL6173352

SCHEMBL6173352

CC(c1ccncc1N1CCCCC1)C1(C(C)c2ccncc2N2CCCCC2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.35
GAA P10253 2/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PDE2A O00408 1/20 0.35
CCR6 P51684 1/20 0.34
LIPE Q05469 3/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MCHR1 Q99705 2/20 0.33
NPBWR1 P48145 1/20 0.33
CACNA2D1 P54289 1/20 0.33
CACNA2D2 Q9NY47 1/20 0.33
GPR139 Q6DWJ6 1/20 0.32
DPP4 P27487 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174909 0.92 TRPV4 (0.37) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173842 0.91 PRKDC (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6202665 0.85 SMN1; SMN2 (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173429 0.84 POLB (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173665 0.83 MAPT (0.36) GAAALDH1A1POLBL3MBTL1PDE2A
SCHEMBL6173283 0.83 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173690 0.82 CYP3A4 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173635 0.81 CCR6 (0.35) POLBL3MBTL1PDE2ACCR6KDM4E
SCHEMBL6172522 0.81 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173440 0.81 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed